CNTNAP3C
gene geneOn this page
Summary
CNTNAP3C (contactin associated protein family member 3C, HGNC:53878) is a protein-coding gene on chromosome 9q12.
Predicted to be involved in cell adhesion. Predicted to be located in membrane.
Source: NCBI Gene 100289279 — RefSeq curated summary.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53878 |
| Approved symbol | CNTNAP3C |
| Name | contactin associated protein family member 3C |
| Location | 9q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000283378 |
| Ensembl biotype | protein_coding |
| Entrez | 100289279 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000636699
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000636699 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003792581 | 61452887 | 61453030 |
| ENSE00003792924 | 61379875 | 61380068 |
| ENSE00003794646 | 61330717 | 61331052 |
| ENSE00003795935 | 61441463 | 61441647 |
| ENSE00003796308 | 61447338 | 61447599 |
| ENSE00003796422 | 61352014 | 61352124 |
| ENSE00003797075 | 61425702 | 61425849 |
| ENSE00003798122 | 61442873 | 61443016 |
| ENSE00003798230 | 61440605 | 61440808 |
Expression profiles
Bgee: expression breadth broad, 93 present calls, max score 80.89.
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.89 | gold quality |
| sural nerve | UBERON:0015488 | 80.16 | gold quality |
| bone marrow | UBERON:0002371 | 71.70 | gold quality |
| blood | UBERON:0000178 | 69.73 | gold quality |
| bone marrow cell | CL:0002092 | 66.25 | gold quality |
| mucosa of stomach | UBERON:0001199 | 60.76 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 57.63 | gold quality |
| lower esophagus | UBERON:0013473 | 57.60 | gold quality |
| cortical plate | UBERON:0005343 | 56.64 | gold quality |
| corpus callosum | UBERON:0002336 | 55.02 | gold quality |
| colonic epithelium | UBERON:0000397 | 53.09 | silver quality |
| esophagus | UBERON:0001043 | 52.50 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 52.42 | gold quality |
| right atrium auricular region | UBERON:0006631 | 51.85 | gold quality |
| tonsil | UBERON:0002372 | 51.63 | silver quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 51.59 | gold quality |
| placenta | UBERON:0001987 | 51.52 | gold quality |
| skin of abdomen | UBERON:0001416 | 50.32 | gold quality |
| right lung | UBERON:0002167 | 48.77 | gold quality |
| zone of skin | UBERON:0000014 | 48.32 | gold quality |
| esophagus mucosa | UBERON:0002469 | 47.45 | gold quality |
| islet of Langerhans | UBERON:0000006 | 46.80 | gold quality |
| skin of leg | UBERON:0001511 | 46.78 | gold quality |
| heart | UBERON:0000948 | 46.21 | gold quality |
| ventricular zone | UBERON:0003053 | 45.82 | gold quality |
| minor salivary gland | UBERON:0001830 | 44.78 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 44.37 | gold quality |
| muscle tissue | UBERON:0002385 | 43.82 | gold quality |
| right uterine tube | UBERON:0001302 | 43.79 | silver quality |
| calcaneal tendon | UBERON:0003701 | 43.78 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.06 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cntnap3 | ENSDARG00000067824 |
| mus_musculus | Cntnap3 | ENSMUSG00000033063 |
| rattus_norvegicus | Cntnap3 | ENSRNOG00000027309 |
Paralogs (35): NRXN3 (ENSG00000021645), TLL1 (ENSG00000038295), CP (ENSG00000047457), DCBLD2 (ENSG00000057019), HEPH (ENSG00000089472), TLL2 (ENSG00000095587), NRP1 (ENSG00000099250), PCOLCE (ENSG00000106333), CNTNAP3 (ENSG00000106714), CUBN (ENSG00000107611), CNTNAP1 (ENSG00000108797), NRXN2 (ENSG00000110076), MEP1A (ENSG00000112818), NRP2 (ENSG00000118257), CUZD1 (ENSG00000138161), MFGE8 (ENSG00000140545), MEP1B (ENSG00000141434), PDGFC (ENSG00000145431), CNTNAP4 (ENSG00000152910), CNTNAP3B (ENSG00000154529), CNTNAP5 (ENSG00000155052), CDCP2 (ENSG00000157211), PCOLCE2 (ENSG00000163710), EDIL3 (ENSG00000164176), NETO1 (ENSG00000166342), BMP1 (ENSG00000168487), PDGFD (ENSG00000170962), NETO2 (ENSG00000171208), CNTNAP2 (ENSG00000174469), NRXN1 (ENSG00000179915), HEPHL1 (ENSG00000181333), F8 (ENSG00000185010), ASTL (ENSG00000188886), F5 (ENSG00000198734), MFRP (ENSG00000235718)
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (1): A0A1B0GTE1
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chr9q12
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
3198 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:61379886:T:A | W70R | 0.998 |
| 9:61379886:T:C | W70R | 0.998 |
| 9:61379961:G:C | A95P | 0.998 |
| 9:61379888:G:C | W70C | 0.997 |
| 9:61379888:G:T | W70C | 0.997 |
| 9:61379968:A:C | Q97P | 0.994 |
| 9:61379959:T:A | V94D | 0.993 |
| 9:61380038:G:C | W120C | 0.993 |
| 9:61380038:G:T | W120C | 0.993 |
| 9:61425778:G:C | R156P | 0.993 |
| 9:61425823:G:C | R171P | 0.993 |
| 9:61379920:T:C | L81P | 0.992 |
| 9:61379969:A:C | Q97H | 0.992 |
| 9:61379969:A:T | Q97H | 0.992 |
| 9:61447462:G:C | R399P | 0.992 |
| 9:61380036:T:A | W120R | 0.991 |
| 9:61380036:T:C | W120R | 0.991 |
| 9:61425716:C:A | N135K | 0.991 |
| 9:61425716:C:G | N135K | 0.991 |
| 9:61379970:G:A | G98R | 0.990 |
| 9:61379970:G:C | G98R | 0.990 |
| 9:61425781:T:C | F157S | 0.990 |
| 9:61379955:G:C | A93P | 0.989 |
| 9:61379971:G:A | G98E | 0.989 |
| 9:61379971:G:T | G98V | 0.989 |
| 9:61380003:T:G | Y109D | 0.989 |
| 9:61425838:G:A | G176E | 0.988 |
| 9:61452912:G:C | W453C | 0.988 |
| 9:61452912:G:T | W453C | 0.988 |
| 9:61379993:G:C | W105C | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1000104938 (9:61406631 C>G), RS1000140106 (9:61344373 C>A,T), RS1000184691 (9:61375628 G>A), RS1000342225 (9:61370671 TC>T,TCC), RS1000356365 (9:61416084 T>G), RS1000428464 (9:61344083 A>T), RS1000523773 (9:61400243 T>A), RS1000538226 (9:61337719 A>G), RS1000603107 (9:61338108 C>T), RS1000616571 (9:61378000 G>C), RS1000717249 (9:61377642 G>GC), RS1000721478 (9:61385941 CAAAG>C), RS1000816774 (9:61386392 G>A), RS1000860567 (9:61363357 C>T), RS1000961867 (9:61417755 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aminomethylphosphonic acid (AMPA) | increases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| 2,4-Dichlorophenoxyacetic Acid | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.